Glazer Capital LLC’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Glazer Capital LLC’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-715,000	Closed	-$15M	–	108
2016 Q3	$15M	Buy	+715,000	New	+$8.23M	2.92%	12

Glazer Capital LLC's VTAE Position: Q4 2016 in Review

Glazer Capital LLC sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 715,000 shares — an estimated $15M sold.

Glazer Capital LLC first reported a position in VTAE in Q3 2016 and held it in 1 quarter. The position peaked at $15M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Glazer Capital LLC reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Glazer Capital LLC sold 715,000 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $15M.
Glazer Capital LLC first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2016 and held it in 1 quarter.
Glazer Capital LLC's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $15M in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Glazer Capital LLC's 13F filing for Q4 2016, filed 14 Feb 2017.